New insights into the role of angiotensin-converting enzyme obtained from the analysis of genetically modified mice

Journal of Molecular Medicine

Volumn 86, Issue 6, 2008, Pages 679-684

  Shen, Xiao Z ^a   Xiao, Hong D ^a   Li, Ping ^a   Lin, Chentao X ^a   Billet, Sandrine ^a   Okwan Duodu, Derick ^a   Adams, Jon W ^a   Bernstein, Ellen A ^a   Xu, Yi ^a   Fuchs, Sebastien ^a   Bernstein, Kenneth E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme; Gene targeting; Heart; Macrophages; Mice; Tissue specific expression

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE;

ANEMIA; BLOOD PRESSURE REGULATION; CATALYSIS; DIPEPTIDYL CARBOXYPEPTIDASE GENE; DNA MODIFICATION; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; IMMUNE RESPONSE; KNOCKOUT MOUSE; MACROPHAGE; NONHUMAN; POINT MUTATION; PROMOTER REGION; REVIEW; WESTERN BLOTTING; WILD TYPE;

ANIMALS; CATALYTIC DOMAIN; MACROPHAGES; MICE; MICE, KNOCKOUT; MUTATION; ORGAN SPECIFICITY; PEPTIDYL-DIPEPTIDASE A;

EID: 43449136744     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-008-0325-3     Document Type: Review

References (36)

1. Bernstein KE, Martin BM, Bernstein EA, Linton J, Striker L, Striker G (1988) The isolation of angiotensin-converting enzyme cDNA. J Biol Chem 263:11021-11024
2. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P (1988) Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A 85:9386-9390
3. Bernstein KE, Martin BM, Edwards AS, Bernstein EA (1989) Mouse angiotensin-converting enzyme is a protein composed of two homologous domains. J Biol Chem 264:11945-11951
4. Ehlers MR, Fox EA, Strydom DJ, Riordan JF (1989) Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci U S A 86:7741-7745
5. Howard TE, Shai SY, Langford KG, Martin BM, Bernstein KE (1990) Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene. Mol Cell Biol 10:4294-4302
6. Langford KG, Shai SY, Howard TE, Kovac HJ, Overbeek PA, Bernstein KE (1991) Transgenic mice demonstrate a testis-specific promoter for angiotensin-converting enzyme. J Biol Chem 266:15559-15562
7. Ehlers MR, Chen YN, Riordan JF (1992) The unique N-terminal sequence of testis angiotensin-converting enzyme is heavily O-glycosylated and unessential for activity or stability. Biochem Biophys Res Commun 183:199-205
8. Wei L, Alhenc-Gelas F, Soubrier F, Michaud A, Corvol P, Clauser E (1991) Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem 266:5540-5546
9. Williams TA, Michaud A, Houard X, Chauvet MT, Soubrier F, Corvol P (1996) Drosophila melanogaster angiotensin I-converting enzyme expressed in Pichia pastoris resembles the C domain of the mammalian homologue and does not require glycosylation for secretion and enzymic activity. Biochem J 318(Pt 1):125-131
10. Riviere G, Michaud A, Corradi HR, Sturrock ED, Ravi Acharya K, Cogez V, Bohin JP, Vieau D, Corvol P (2007) Characterization of the first angiotensin-converting like enzyme in bacteria: ancestor ACE is already active. Gene 399:81-90
11. Coates D (2003) The angiotensin converting enzyme (ACE). Int J Biochem Cell Biol 35:769-773
12. Harmer D, Gilbert M, Borman R, Clark KL (2002) Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 532:107-110
13. Ryan US, Ryan JW, Whitaker C, Chiu A (1976) Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell 8:125-145
14. Cushman DW, Cheung HS (1971) Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta 250:261-265
15. Danilov SM, Sadovnikova E, Scharenborg N, Balyasnikova IV, Svinareva DA, Semikina EL, Parovichnikova EN, Savchenko VG, Adema GJ (2003) Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells. Exp Hematol 31:1301-1309
16. Saijonmaa O, Nyman T, Fyhrquist F (2007) Atorvastatin inhibits angiotensin-converting enzyme induction in differentiating human macrophages. Am J Physiol Heart Circ Physiol 292:H1917-H1921
17. Erdos EG, Schulz WW, Gafford JT, Defendini R (1985) Neutral metalloendopeptidase in human male genital tract. Comparison to angiotensin I-converting enzyme. Lab Invest 52:437-447
18. van Sande ME, Scharpe SL, Neels HM, Van Camp KO (1985) Distribution of angiotensin converting enzyme in human tissues. Clin Chim Acta 147:255-260
19. Hooper NM (1991) Angiotensin converting enzyme: implications from molecular biology for its physiological functions. Int J Biochem 23:641-647
20. Natesh R, Schwager SL, Sturrock ED, Acharya KR (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421:551-554
21. Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O (1995) Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146-148
22. Esther CR Jr, Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KE (1996) Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74:953-965
23. Fuchs S, Xiao HD, Cole JM, Adams JW, Frenzel K, Michaud A, Zhao H, Keshelava G, Capecchi MR, Corvol P, Bernstein KE (2004) Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice. J Biol Chem 279:15946-15953
24. Fuchs S, Xiao HD, Hubert C, Michaud A, Campbell DJ, Adams JW, Capecchi MR, Corvol P, Bernstein KE (2008) Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin i cleavage in vivo. Hypertension 51(2):267-274
25. Lenfant M, Wdzieczak-Bakala J, Guittet E, Prome JC, Sotty D, Frindel E (1989) Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc Natl Acad Sci U S A 86:779-782
26. Cole J, Quach DL, Sundaram K, Corvol P, Capecchi MR, Bernstein KE (2002) Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure. Circ Res 90:87-92
27. Xiao HD, Fuchs S, Campbell DJ, Lewis W, Dudley SC Jr, Kasi VS, Hoit BD, Keshelava G, Zhao H, Capecchi MR, Bernstein KE (2004) Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 165:1019-1032
28. Dahlof B (1995) Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. J Hum Hypertens 5(9 Suppl):S37-S44
29. Pillai JB, Gupta M, Rajamohan SB, Lang R, Raman J, Gupta MP (2006) Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 291:H1545-H1553
30. Kasi VS, Xiao HD, Shang LL, Iravanian S, Langberg J, Witham EA, Jiao Z, Gallego CJ, Bernstein KE, Dudley SC Jr (2007) Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation. Am J Physiol Heart Circ Physiol 293:H182-H192
31. Xiao HD, Fuchs S, Bernstein EA, Li P, Campbell DJ, Bernstein KE (2008) Mice expressing ACE only in the heart show that increased cardiac angiotensin II is not associated with cardiac hypertrophy. Am J Physiol Heart Circ Physiol 294:H659-H667
32. Reudelhuber TL, Bernstein KE, Delafontaine P (2007) Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look. Hypertension 49:1196-1201
33. Shen XZ, Li P, Weiss D, Fuchs S, Xiao HD, Adams JA, Williams IR, Capecchi MR, Taylor WR, Bernstein KE (2007) Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Am J Pathol 170:2122-2134
34. Uemura H, Ishiguro H, Kubota Y (2006) Angiotensin II receptor blocker: possibility of antitumor agent for prostate cancer. Mini Rev Med Chem 6:835-844
35. Ino K, Shibata K, Kajiyama H, Nawa A, Nomura S, Kikkawa F (2006) Manipulating the angiotensin system-new approaches to the treatment of solid tumours. Expert Opin Biol Ther 6:243-255
36. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi M, Ikeda H, Matsuishi T, Imaizumi T (2003) Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112:67-75